Glycosaminoglycans of pleural mesothelioma: A possible biochemical variant containing chondroitin sulfate

28Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Glycosaminoglycans of a malignant pleural mesothelioma have been characterized histochemically and biochemically and compared with those of normal lung, pleural plaque, lung carcinoma, and other connective tissue neoplasms. Chondroitin sulfate constituted the major glycosaminoglycan (∼80% of total) present in the pleural mesothelioma while hyaluronic acid was present in only trace amounts (∼3% of total). In particular chondroitin 6‐sulfate was the predominant isomer, constituting 80% of the total chondroitin sulfate. Control tissue exhibited different proportions of glycosaminoglycans and none of them contained as high an absolute concentration of chondroitin sulfate as the mesothelioma. These findings differ from previous reports demonstrating increased concentration of hyaluronic acid in mesothelioma and suggest the possible existence of a biochemically different form of this neoplasm. Copyright © 1981 American Cancer Society

Cite

CITATION STYLE

APA

Iozzo, R. V., Goldes, J. A., Chen, W. ‐J, & Wight, T. N. (1981). Glycosaminoglycans of pleural mesothelioma: A possible biochemical variant containing chondroitin sulfate. Cancer, 48(1), 89–97. https://doi.org/10.1002/1097-0142(19810701)48:1<89::AID-CNCR2820480118>3.0.CO;2-B

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free